Announcement on behalf of OBIGEN that BOD resolved to apply for public offering and listing in the TPEx Emerging Stock Board

Date of occurrence of the event:2025/03/18 Company name: OBIGEN Pharma, Inc. Relationship to the Company (please enter ”head office” or ”subsidiaries”):subsidiaries Reciprocal shareholding ratios: OBIGEN is a subsidiary held 51.94% of voting shares by the Company Cause of occurrence: To achieve sustainable development and attract professional talents, OBIGEN plans to file the application to Taipei […]